Frederick, Megan A. http://orcid.org/0000-0002-3808-8744
Williamson, Kaylyn E. http://orcid.org/0000-0002-3252-5050
Fernandez Garcia, Meilin
Ferretti, Max B. http://orcid.org/0000-0003-2961-6362
McCarthy, Ryan L.
Donahue, Greg
Luzete Monteiro, Edgar
Takenaka, Naomi
Reynaga, Janice
Kadoch, Cigall http://orcid.org/0000-0002-4058-5985
Zaret, Kenneth S. http://orcid.org/0000-0001-8932-3145
Article History
Received: 15 April 2022
Accepted: 3 November 2022
First Online: 19 December 2022
Competing interests
: C.K. is the Scientific Founder, fiduciary Board of Directors member, Scientific Advisory Board member, shareholder and consultant for Foghorn Therapeutics, Inc. C.K. also serves on the scientific advisory boards of Nereid Therapeutics and Nested Therapeutics and is a consultant for Cell Signaling Technologies. K.E.W. is an employee and shareholder of Flare Therapeutics. The remaining authors declare no competing interests.